More recently, an experiment carried out on patients with different types of dementia and mild cognitive impairment (MCI) demonstrated that soluble‐TRAIL levels in serum were higher in vascular dementia (VAD), 'mixed' dementia (MIX) and MCI patients, compared with late‐onset AD (LOAD) patients and the controls. This evidence concerns the gene TNFSF10 and Alzheimer disease.